Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94-32 central Asian/Russian clusters.

Klotoe BJ, Kacimi S, Costa-Conceicão E, Gomes HM, Barcellos RB, Panaiotov S, Haj Slimene D, Sikhayeva N, Sengstake S, Schuitema AR, Akhalaia M, Alenova A, Zholdybayeva E, Tarlykov P, Anthony R, Refrégier G, Sola C.

BMC Infect Dis. 2019 Jun 24;19(1):553. doi: 10.1186/s12879-019-4201-2.

2.

Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.

Sengstake S, Bergval IL, Schuitema AR, de Beer JL, Phelan J, de Zwaan R, Clark TG, van Soolingen D, Anthony RM.

BMC Infect Dis. 2017 Jul 12;17(1):491. doi: 10.1186/s12879-017-2594-3.

3.

A proportion of mutations fixed in the genomes of in vitro selected isogenic drug-resistant Mycobacterium tuberculosis mutants can be detected as minority variants in the parent culture.

Bergval I, Coll F, Schuitema A, de Ronde H, Mallard K, Pain A, McNerney R, Clark TG, Anthony RM.

FEMS Microbiol Lett. 2015 Jan;362(2):1-7. doi: 10.1093/femsle/fnu037. Epub 2014 Dec 4.

4.

Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates.

Sengstake S, Bablishvili N, Schuitema A, Bzekalava N, Abadia E, de Beer J, Tadumadze N, Akhalaia M, Tuin K, Tukvadze N, Aspindzelashvili R, Bachiyska E, Panaiotov S, Sola C, van Soolingen D, Klatser P, Anthony R, Bergval I.

BMC Genomics. 2014 Jul 7;15:572. doi: 10.1186/1471-2164-15-572.

5.

Clinical delineation of a patient with trisomy 12q23q24.

Bouman A, Schuitema A, Pfundt R, van de Zande G, Kleefstra T.

Eur J Med Genet. 2013 Aug;56(8):463-9. doi: 10.1016/j.ejmg.2013.06.012. Epub 2013 Jul 10.

PMID:
23851164
6.

Combined species identification, genotyping, and drug resistance detection of Mycobacterium tuberculosis cultures by MLPA on a bead-based array.

Bergval I, Sengstake S, Brankova N, Levterova V, Abadía E, Tadumaze N, Bablishvili N, Akhalaia M, Tuin K, Schuitema A, Panaiotov S, Bachiyska E, Kantardjiev T, de Zwaan R, Schürch A, van Soolingen D, van 't Hoog A, Cobelens F, Aspindzelashvili R, Sola C, Klatser P, Anthony R.

PLoS One. 2012;7(8):e43240. doi: 10.1371/journal.pone.0043240. Epub 2012 Aug 20.

7.

Pre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitro.

Bergval I, Kwok B, Schuitema A, Kremer K, van Soolingen D, Klatser P, Anthony R.

PLoS One. 2012;7(1):e29108. doi: 10.1371/journal.pone.0029108. Epub 2012 Jan 3.

8.

Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.

Bergval IL, Schuitema AR, Klatser PR, Anthony RM.

J Antimicrob Chemother. 2009 Sep;64(3):515-23. doi: 10.1093/jac/dkp237. Epub 2009 Jul 4.

9.

Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia.

Jansen NC, Kingma A, Schuitema A, Bouma A, Veerman AJ, Kamps WA.

J Clin Oncol. 2008 Jun 20;26(18):3025-30. doi: 10.1200/JCO.2007.12.4149.

PMID:
18565888
10.

Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis.

Bergval IL, Vijzelaar RN, Dalla Costa ER, Schuitema AR, Oskam L, Kritski AL, Klatser PR, Anthony RM.

J Clin Microbiol. 2008 Feb;46(2):689-99. Epub 2007 Dec 12.

11.

Specific mutations in the Mycobacterium tuberculosis rpoB gene are associated with increased dnaE2 expression.

Bergval IL, Klatser PR, Schuitema AR, Oskam L, Anthony RM.

FEMS Microbiol Lett. 2007 Oct;275(2):338-43. Epub 2007 Sep 14.

12.

Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: a prospective, sibling-controlled study.

Jansen NC, Kingma A, Schuitema A, Bouma A, Huisman J, Veerman AJ, Kamps WA.

Eur J Cancer. 2006 Nov;42(16):2765-72. Epub 2006 Aug 28.

PMID:
16935489
13.

Catecholase activity of a copper(II) complex with a macrocyclic ligand: unraveling catalytic mechanisms.

Koval IA, Selmeczi K, Belle C, Philouze C, Saint-Aman E, Gautier-Luneau I, Schuitema AM, van Vliet M, Gamez P, Roubeau O, Lüken M, Krebs B, Lutz M, Spek AL, Pierre JL, Reedijk J.

Chemistry. 2006 Aug 7;12(23):6138-50.

PMID:
16832797
14.

Catecholase activity of a mu-hydroxodicopper(II) macrocyclic complex: structures, intermediates and reaction mechanism.

Koval IA, Belle C, Selmeczi K, Philouze C, Saint-Aman E, Schuitema AM, Gamez P, Pierre JL, Reedijk J.

J Biol Inorg Chem. 2005 Nov;10(7):739-50. Epub 2005 Nov 8.

PMID:
16208496
15.

Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency.

Anthony RM, Schuitema AR, Bergval IL, Brown TJ, Oskam L, Klatser PR.

Ann Clin Microbiol Antimicrob. 2005 Jun 15;4:9.

16.

Proton NMR spectroscopy and magnetic properties of a solution-stable dicopper(II) complex bearing a single mu-hydroxo bridge.

Koval IA, van der Schilden K, Schuitema AM, Gamez P, Belle C, Pierre JL, Lüken M, Krebs B, Roubeau O, Reedijk J.

Inorg Chem. 2005 Jun 13;44(12):4372-82. Erratum in: Inorg Chem. 2005 Dec 26;44(26):9977.

PMID:
15934768
17.

Direct detection of Staphylococcus aureus mRNA using a flow through microarray.

Anthony RM, Schuitema AR, Oskam L, Klatser PR.

J Microbiol Methods. 2005 Jan;60(1):47-54.

PMID:
15567224
18.

Comparison of PCR with the routine procedure for diagnosis of tuberculosis in a population with high prevalences of tuberculosis and human immunodeficiency virus.

Kivihya-Ndugga L, van Cleeff M, Juma E, Kimwomi J, Githui W, Oskam L, Schuitema A, van Soolingen D, Nganga L, Kibuga D, Odhiambo J, Klatser P.

J Clin Microbiol. 2004 Mar;42(3):1012-5.

19.

Effect of secondary structure on single nucleotide polymorphism detection with a porous microarray matrix; implications for probe selection.

Anthony RM, Schuitema AR, Chan AB, Boender PJ, Klatser PR, Oskam L.

Biotechniques. 2003 May;34(5):1082-6, 1088-9.

20.

Diagnosis of infections caused by Enterocytozoon bieneusi and Encephalitozoon intestinalis using polymerase chain reaction in stool specimens.

Liguory O, David F, Sarfati C, Schuitema AR, Hartskeerl RA, Derouin F, Modaï J, Molina JM.

AIDS. 1997 May;11(6):723-6.

PMID:
9143603
21.

Detection and species identification of intestinal microsporidia by polymerase chain reaction in duodenal biopsies from human immunodeficiency virus-infected patients.

David F, Schuitema AR, Sarfati C, Liguory O, Hartskeerl RA, Derouin F, Molina JM.

J Infect Dis. 1996 Oct;174(4):874-7.

PMID:
8843234
22.
23.

Genetic evidence for the occurrence of extra-intestinal Enterocytozoon bieneusi infections.

Hartskeerl RA, Schuitema AR, van Gool T, Terpstra WJ.

Nucleic Acids Res. 1993 Aug 25;21(17):4150. No abstract available.

24.

Secondary structure of the small subunit ribosomal RNA sequence of the microsporidium Encephalitozoon cuniculi.

Hartskeerl RA, Schuitema AR, deWachter R.

Nucleic Acids Res. 1993 Mar 25;21(6):1489. No abstract available.

25.

Detection of Mycobacterium tuberculosis in clinical samples by using polymerase chain reaction and a nonradioactive detection system.

Kolk AH, Schuitema AR, Kuijper S, van Leeuwen J, Hermans PW, van Embden JD, Hartskeerl RA.

J Clin Microbiol. 1992 Oct;30(10):2567-75.

26.
27.

Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis.

Hermans PW, van Soolingen D, Dale JW, Schuitema AR, McAdam RA, Catty D, van Embden JD.

J Clin Microbiol. 1990 Sep;28(9):2051-8.

28.

Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction.

Hermans PW, Schuitema AR, Van Soolingen D, Verstynen CP, Bik EM, Thole JE, Kolk AH, van Embden JD.

J Clin Microbiol. 1990 Jun;28(6):1204-13.

29.

Suppression of IIIGlc-defects by enzymes IINag and IIBgl of the PEP:carbohydrate phosphotransferase system.

Vogler AP, Broekhuizen CP, Schuitema A, Lengeler JW, Postma PW.

Mol Microbiol. 1988 Nov;2(6):719-26.

PMID:
3062308
30.

Relationship between pseudo-HPr and the PEP: fructose phosphotransferase system in Salmonella typhimurium and Escherichia coli.

Geerse RH, Ruig CR, Schuitema AR, Postma PW.

Mol Gen Genet. 1986 Jun;203(3):435-44.

PMID:
3528748
31.
32.

Molecular cloning, sequencing, and expression of the crr gene: the structural gene for IIIGlc of the bacterial PEP:glucose phosphotransferase system.

Nelson SO, Schuitema AR, Benne R, van der Ploeg LH, Plijter JS, Aan F, Postma PW.

EMBO J. 1984 Jul;3(7):1587-93.

33.
34.
35.
36.

Supplemental Content

Loading ...
Support Center